BillionToOne is growing rapidly in prenatal and oncology testing. Click here to explore BLLN's financials, market risks, and ...

Approval of J&J's Darzalex marks a milestone for high-risk sMM patients, but GlobalData analyst Biswajit Podder believes ...

The new EU regulation introduces Joint Clinical Assessments that will run in parallel with EMA approvals, delivering comparative effectiveness data within one month of market authorisation.

Lumonus, a leader in AI powered radiation oncology workflow solutions, today announced the close of its A$25 million Series B financing round. The round was led by Aviron Investment Management with ...

Driven by the rapid advancements in artificial intelligence, computational pathology is emerging as a critical engine in the era of precision ...

The FDA accepted the investigational new drug application for UGN-103 in April 2024. These new positive data position the ...

Genetic testing company Natera (NASDAQ:NTRA). in Q3 CY2025, with sales up 34.7% year on year to $592.2 million. The company’s ...

The term “AI nurse” is appearing with increasing frequency in healthcare technology pitches and product descriptions. But for many nursing leaders, it is a line that should not be crossed. Titles such ...

As cancer cases rise across India, oncologists stress that early detection and awareness must advance alongside medical ...

Q3 2025 Earnings Call Transcript November 6, 2025 Novavax, Inc. misses on earnings expectations. Reported EPS is $-1.24654 ...

AI may help radiologists evaluate mammograms for breast cancer more effectively, but researchers at UCLA, UC Davis and ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, /PRNewswire/ -- Harbour BioMed ('HBM' or the 'Company'; HKEX: 02142), a global biopharmaceutical company committed to the discovery and ...